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Long-term results of pancreaticoduodenectomy and endoscopic
resection in the treatment of early stage carcinoma of the
ampulla of Vater: case series and review of the literature
Abdulkadir DÖKMECİ, Mustafa YAKUT, Necati ÖRMECİ, Hasan ÖZKAN, Gökhan KABAÇAM

Abstract: We retrospectively evaluated 6 cases to explore the role of curative pancreaticoduodenectomy and endoscopic
resection of ampulla of Vater tumors. Six patients diagnosed with stage 1 ampullary tumors at Ankara University
Hospital between January 1994 and September 2009 were analyzed retrospectively. Icterus was the cardinal symptom
in all patients. The median time for the symptoms caused by the lesion of the papilla was 7 weeks in patients with
carcinoma. The diameters of the visualized tumors were less than 20 mm. Diabetes mellitus was observed in 2 patients.
When the patients were classified according to TNM staging, all patients were in stage 1. Endoscopic resection was
performed in 3 patients, and the other 3 patients underwent curative pancreaticoduodenectomy. The mean ages in
the curative pancreaticoduodenectomy group and endoscopic resection group were 54.3 and 80.3 years, respectively.
Tumor recurrence was not observed in any patient. Among the endoscopic resection group, there was no sign of tumor
recurrence for 72 months in 1 patient, 6 months in another patient, and 46 months in the last patient. One of the
patients died 46 weeks after endoscopic ampullectomy. This patient also had diabetes mellitus and cardiac problems.
Radical pancreaticoduodenectomy is presently the most common method for resecting malignant ampullary tumors.
Endoscopic resection of carcinoma of the ampulla of Vater appears to be an alternative to surgical therapy, particularly
in patients for whom surgical approach carries a high risk.
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Introduction
Carcinoma of the papilla has a distinctive status
among the periampullary carcinomas, as it carries
a relatively favorable prognosis. Early and accurate
diagnosis of carcinoma of the ampulla of Vater
would lead to early treatment and, subsequently, a
better prognosis (1). In stage 1, visualized tumors
have diameters of less than 2 cm (2). The symptoms
arising due to these tumors are nonspecific and not
always evident (1). The most common presenting
symptom is jaundice.
Optimal management of neoplastic diseases
of the papilla of Vater is still controversial. Until

recently, surgical resections or transduodenal local
excisions were routinely performed in most centers
as definitive treatments (3). Carcinoma of the
papilla of Vater is usually localized at the time of
diagnosis, and prolonged survival can be obtained by
curative surgery. Therefore, an aggressive approach
in such patients is reasonable (2-4). In recent years,
endoscopic resection procedures have proven to be
feasible and safe alternatives for neoplastic diseases
of the papilla, but further controlled studies with
long-term data are needed to evaluate preoperative
staging accuracy and recurrence rates (3,5-7). Local
resection is especially indicated for older patients
with high risk or severe concurrent diseases. Close

Received: 14.10.2010 – Accepted: 10.08.2011
Department of Gastroenterology, Faculty of Medicine, Ankara University, Ankara - TURKEY
Correspondence: Mustafa YAKUT, Department of Gastroenterology, Faculty of Medicine, Ankara University, Ankara - TURKEY
E-mail: musyakut@gmail.com

946

A. DÖKMECİ, M. YAKUT, N. ÖRMECİ, H. ÖZKAN, G. KABAÇAM

postoperative follow-up with duodenoscopy and
endoscopic retrograde cholangiopancreatography
(ERCP) is recommended (7,8).
Our aim was to evaluate retrospectively 6 cases
of ampulla of Vater tumors at Ankara University
Hospital and to establish the role of curative
pancreaticoduodenectomy and endoscopic resection
of the papilla in the long-term survival rate of
patients.
Case reports
Six patients diagnosed with stage 1 ampulla of Vater
tumors at Ankara University Hospital between January 1994 and September 2009 were analyzed retrospectively. The surgical techniques for managing ampullary cancer include pancreaticoduodenectomy.
Surgery in ampulla of Vater cancer without distant
metastasis is indicated by preoperative evaluation
of computed tomography (CT) images of the abdomen and pelvis. Endoscopic resection of the papilla
includes removal of the intraduodenal roof and removal of the intraluminal common orifice of the papilla (Figures 1a-1c).

Figure 1b. The protruding papilla is observed in ERCP.

Tumor size and differentiation, venous invasion,
and lymph node status were assessed. Tumor infiltration depths (T stage) of ampullary cancer were recorded according to the sixth edition of the American
Joint Committee on Cancer staging system (9): pTis,
carcinoma in situ; pT1, tumor limited to the ampulla
of Vater or the sphincter of Oddi; pT2, tumor invad-

Figure 1c. Endoscopic resection of tumors of the ampulla of
Vater.

Figure 1a. Both choledoch and pancreatic canal terminate
enlarged at the level of ampulla in the MRCP image.

ing the duodenal wall; pT3, tumor invading the pancreas; and pT4, tumor invading peripancreatic soft
tissues or other adjacent organs.
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After curative resection for ampulla of Vater neoplasms, all patients underwent 2 to 8 follow-up examinations including routine CT scans. Survival was
calculated in months from the date of the diagnosis
until last follow-up attendance or death.
We reviewed the medical records of 6 patients.
The median time for patient symptoms caused by
the lesion of the papilla was 7 weeks in patients with
carcinoma. Clinical manifestations in patients with
carcinoma (n = 6) were as follows: epigastric pain in 1; jaundice in 6; and weight loss in 2. Diabetes mellitus was
observed in 2 patients with carcinoma. All of the patients were admitted with a main complaint of jaundice. Icterus was the cardinal symptom in all patients.
The tumors were visualized with diameters of less
than 20 mm. Dilation in the bile duct was demonstrated in all patients who underwent ultrasound or
CT scan. Endoscopic imaging discovered the tumor
in all cases; however, biopsy had a diagnostic value in
only 5 patients.
There was no lymph node metastasis in any patient. When the patients were classified according
to pTNM staging, all patients were in stage 1. Three
patients underwent curative pancreaticoduodenectomy. Surgical ampullectomy was not performed in
any of the patients. Three patients underwent endoscopic resection; 2 of the patients were male and 1
was female. The mean age in the curative pancreaticoduodenectomy group was 54.3 years, ranging from
52 to 57 years. In the endoscopic resection group,
the mean age was 80.3 years, ranging from 67 to 96
years. Tumor recurrence and hospital mortality were
not observed in either patient group. In November
2009, 5 of the 6 patients were alive. In the pancreaticoduodenectomy group, the patients were followed for 12 to 132 months. Among the endoscopic
resection group, there were not any signs of tumor
recurrence for 72 months in 1 patient, for 6 months
in another patient, and for 46 months in the final patient. Because of the high rate of comorbidities and
the advanced age of some of the patients (3 of the 6
were older than 70 years), additional radical surgical
procedures were not performed on these 3 patients.
One of the patients died 46 weeks after endoscopic
ampullectomy. This patient also had diabetes mellitus
and cardiac problems.
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Discussion
Carcinoma of the ampulla of Vater is rare. The
symptoms of these tumors are usually nonspecific
(1). The most common presenting symptoms are
jaundice and abdominal pain. In this study, all of
the patients were admitted with a main complaint of
jaundice. ERCP with biopsy is a minimally invasive
technique used to visualize these tumors directly
and to evaluate their histological characteristics.
Histological examination of samples obtained via
forceps biopsies reveals malignancy in only 60% of
cases. When a snare biopsy is used, the diagnostic
yield increases to 83% (2,10). All of our patients were
diagnosed by ERCP.
These tumors are clinically important and early
identification, appropriate staging, and proper
treatment are essential for a better prognosis (1,2).
These tumors are usually visualized with a diameter
of less than 2 cm (5). Factors having prognostic value
for survival rate are the stage of disease, metastatic
regional spread, tumor invasion in the head of
the pancreas, and the microscopic appearance of
pancreatitis in the acute phase of the condition
(11,12). Tumors of the ampulla of Vater have a
favorable prognosis. The facts responsible for this
in the majority of cases are the early appearance of
symptoms due to proximity to the common bile duct
and restriction of the metastases to the lymphatic
nodes (1,2,10,13). In our study, the tumors were
restricted within the papilla in all of the patients.
There were no lymph node metastases or distant
metastases. Tumor diameters were less than 2 cm.
There is no consensus yet regarding the optimal
management of neoplastic diseases of the papilla
of Vater. Curative treatment may be performed
endoscopically or surgically (1,3,8). Radical resection
for ampullary carcinoma remains the procedure of
first choice in these patients (6). Carcinoma of the
papilla of Vater is usually localized at the time of
diagnosis, and prolonged survival can be obtained by
pancreaticoduodenectomy, especially when no nodal
or distant metastases are present at the time of surgery.
An aggressive approach, therefore, is reasonable in
such patients (8,14-16). Pancreaticoduodenectomy
has the advantage of a low recurrence rate with
low perioperative mortality (0%-3%) and an
acceptable survival rate (15%-25%) (13,17). Local
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surgical excision (surgical ampullectomy) has the
advantage of lower morbidity (0%-25%), but also has
higher recurrence rates and requires postoperative
endoscopic surveillance (17-19).
In recent years, endoscopic resection procedures
have proven to be feasible and safe alternatives for
the treatment of neoplastic diseases of the papilla,
but further controlled studies with long-term data
are required to evaluate the accuracy of preoperative
staging and recurrence rates (3,5,6). Endoscopic
papillectomy is effective and safe in experienced
hands, usually producing little morbidity and
virtually no mortality (20). In unresectable cases,
endoscopic palliation can increase the survival
rate (21). Local resection is especially indicated for
elderly patients with high risk or severe concomitant
diseases (2,7,22,23). Snare ampullectomy is a novel
endoscopic excisional technique for which limited
data are available; its advantages when compared
with radical surgery are apparent lower mortality
(0%-1%) and morbidity (12%) rates (24). Local

resection has a high rate of recurrence (5%- 30%)
and requires postoperative endoscopic surveillance.
For this reason, it is not considered the first choice for
management of ampullary tumors (20). In patients
who are not candidates for curative treatment,
palliative treatment through drainage can be
performed, preferably via endoscopy (1,16,18).
We preferred endoscopic resection in elderly
patients with comorbidities. Of the 6 patients involved
in the study, 5 were alive as of November 2009.
One patient died after endoscopic ampullectomy.
This patient had comorbid diseases. Recurrence
was not observed in any of the patients after either
pancreaticoduodenectomy or endoscopic resection.
Radical pancreaticoduodenectomy is presently
the most common method for resecting malignant
ampullary tumors. Endoscopic resection of
carcinoma of the ampulla of Vater appears to be a
viable alternative to surgical therapy, particularly in
patients for whom surgical approach carries a high
risk.
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